Bora Pharmaceuticals Co Ltd ADR BORAY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Shares Outstanding
- 127.57M
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 6.40
- Price/Sales
- 0.50
- Dividend Yield (Trailing)
- 2.57%
- Dividend Yield (Forward)
- 2.57%
- Dividend Payment Schedule
- Sep
- Total Yield
- 2.71%
Company Profile
Bora Pharmaceuticals Co Ltd is a pharmaceutical company based in Taiwan. It covers the pharmaceutical supply chain from research and development to sales and distribution. The main activities of the Company focus on manufacturing and selling generic, brand, and over-the-counter (OTC) drugs, contract development and manufacturing (CDMO), and developing and selling consumer healthcare products. The Group operates in three reportable segments; Sales segment: sale of pharmaceuticals, generics, and healthcare products. CDMO segment: contract development and manufacturing organization of pharmaceuticals. Other segment: Others. Geographically, the company operates in the USA which derives key revenue, Europe, Taiwan, and other regions.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 94
- Website
- https://www.bora-corp.com
Valuation
|
Metric
|
BORAY
|
|---|---|
Price/Earnings (Normalized) | 6.40 |
Price/Book Value | 0.66 |
Price/Sales | 0.50 |
Price/Cash Flow | 3.03 |
Price/Earnings
BORAY
Financial Strength
|
Metric
|
BORAY
|
|---|---|
Quick Ratio | 1.01 |
Current Ratio | 1.30 |
Interest Coverage | 6.65 |
Quick Ratio
BORAY
Profitability
|
Metric
|
BORAY
|
|---|---|
Return on Assets (Normalized) | 3.68% |
Return on Equity (Normalized) | 11.87% |
Return on Invested Capital (Normalized) | 5.72% |
Return on Assets
BORAY
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|xFV%qz%^ | LOCK|rFsX | $70B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|Tm^rd&K< | LOCK|G^>S | $48B | |||
| Haleon PLC ADR
HLN
| LOCK|s%X#$? | LOCK|#Sj | $44B | |||
| Zoetis Inc Class A
ZTS
| LOCK|ttfnply | LOCK|Q& | $33B | |||
| Viatris Inc
VTRS
| LOCK|xlNWn&V | LOCK|?xS | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|ht | LOCK|W! | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|!p@Tnj | LOCK|Ps | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|YS@kv$ | LOCK|YP | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|ntlB$> | LOCK|^!vw | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|^lx!qh& | LOCK|zl | $2B |
United States